New Study Expands Range of Potential Alzheimer’s Drugs
Treatments may not need to cross the blood-brain barrier to affect brain insulin resistance
neurodegenerative diseases
New System That Defines Huntington’s Disease Will ‘Revolutionize’ Drug Trials
The new framework groups together people with HD according to their underlying characteristics
New Drug Screening Method Answers Why Alzheimer’s Drugs Fail
Method looks at what disease mechanisms, or endotypes, change in patients’ neurons as a result of treatment
Polymer-Coated Nanoparticles to Promote Drug Delivery to the Brain
Study demonstrates the effectiveness of a nanoparticle-coating polymer for treating neurodegenerative diseases
Could Foods Such as Cheese and Wine Reduce Cognitive Decline?
Recent study is a first-of-its-kind large scale analysis that connects specific foods to later-in-life cognitive acuity
Tomatoes Offer Affordable Source of Parkinson's Disease Drug
The development of the genetically modified tomato has implications for developing nations where access to pharmaceutical drugs is restricted
Studying Brain Disorders at the Source
The Harvard Brain Tissue Resource Center at McLean Hospital provides an essential service to researchers studying complex disorders
Neurological Consequences of COVID-19: The 'Silent Wave'
A research team is examining the potential link between COVID-19 and increased risk of Parkinson's disease, as well as measures to get ahead of the curve
Creating Diamond Devices to Detect Parkinson's Early
MSU's Wen Li and Erin Purcell are leading the effort to use innovative diamond devices to monitor the brain's biochemistry for early warning signs of disease
Gold Nanoparticles to Save Neurons from Cell Death
Study opens important perspectives for treatment of diseases such as Alzheimer's and Huntington's disease, but also epilepsy, brain trauma, and stroke